Ethical Considerations for Unblinding and Vaccinating COVID-19 Vaccine Trial Placebo Group Participants
Saved in:
Main Authors: | Jenna Rose Stoehr (Author), Alireza Hamidian Jahromi (Author), Clayton Thomason (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Discussion of Race and Ethnicity in Real-World Data Sources: Considerations for Medical Device Regulatory Efforts
by: Alireza Hamidian Jahromi, et al.
Published: (2021) -
There is no ethical dilemma with current RCT participant unblinding practices
by: Craig Fry
Published: (2012) -
Staying Connected and Prepared for Collegiate Athletic Competitions During the COVID-19 Pandemic
by: Allie Reynolds, et al.
Published: (2021) -
Why African Americans Are a Potential Target for COVID-19 Infection in the United States
by: Hamidian Jahromi, Alireza, et al.
Published: (2020) -
Transgender Athletes in Sports Competitions: How Policy Measures Can Be More Inclusive and Fairer to All
by: Allie Reynolds, et al.
Published: (2021)